Get the content you want anytime you want.

The Contagion® Healthcare Associated Infections (HAI) specialty page provides HAI-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


Screening and Isolation of <em>C. difficile</em> Carriers Can Lower Incidence of Infections
A new study shows that detecting and isolating Clostridium difficile carriers when they are admitted to hospitals can significantly reduce the incidence of new infections from the pathogen. 
New Genetic Research Holds Promise for <em>C. Difficile</em> Treatment
In the battle against drug-resistant pathogens, genetic research holds promising answers to our toughest threats. A new study shows that the best tool for treating Clostridium difficile infections could be within the genome of the bacteria itself.
Probiotics Could Offer Important Line of Defense Against Drug-resistant Bacteria
As the rise of antibiotic-resistant bacteria leads to higher rates of life-threatening infections from pathogens such Clostridium difficile and methicillin-resistant Staphylococcus aureus (MRSA), researchers are increasingly looking to probiotic treatment as an important part of fighting infections.
Are Phage-based Treatments the Solution for <em>C. difficile</em> Infection?
A new bacteriophage (phage) treatment-based approach to fighting Clostridium difficile (C. difficile) colonization and infection may one day provide for effective treatment against this potentially lethal disease.
Exploring the Future of Vaccines for HAIs
A recent review article on the status of vaccines in development for healthcare associated infections (HAIs) provides both an in-depth discussion of their urgent need, as well as their potential for success.
Interfacility Collaboration May Help Prevent Spread of CDI
Clostridium difficile infection (CDI) can be spread between facilities, particularly in older adults. One study has found that collaboration between facilities may help curb the spread of this potentially deadly infection.
Novel Biologic Agent Could be a Primary Defense Against <i>C. Difficile</i>
Treatment with SER-109 is considered to be effective in treating Clostridium difficile infection.
CDC Calls on Healthcare Professionals to Help Fight Hospital Acquired Infections
US hospitals have made significant reductions in the incidence of hospital-acquired infections (HAIs) over the past decade, a new report from the Centers for Disease Control and Prevention (CDC) has revealed.
We break down our top HIV news stories of 2017. Did you read them all?